A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it's eyeing the pharma industry
A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry
Leave your comment
You must be logged in to post a comment.